Mische, S., Orenstein, R., Dubberke, E. R., Khanna, S., Hecht, G., Dupont, H., . . . Blount, K. (2018). 1950. Prevention of Recurrent Clostridium difficile at Six Months Following Treatment With Microbiota-Based Therapy RBX2660: Durability Results From a Phase 2 Open-Label Study. Open Forum Infect Dis.
Citação norma ChicagoMische, Sarah, Robert Orenstein, Erik R. Dubberke, Sahil Khanna, Gail Hecht, Herbert Dupont, Christine Lee, and Ken Blount. "1950. Prevention of Recurrent Clostridium Difficile At Six Months Following Treatment With Microbiota-Based Therapy RBX2660: Durability Results From a Phase 2 Open-Label Study." Open Forum Infect Dis 2018.
Citação norma MLAMische, Sarah, et al. "1950. Prevention of Recurrent Clostridium Difficile At Six Months Following Treatment With Microbiota-Based Therapy RBX2660: Durability Results From a Phase 2 Open-Label Study." Open Forum Infect Dis 2018.